IRIS
MARCHESE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 35.509
Totale 35.509
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 35.509
Totale 35.509
Salva come PNG Salva come JPEG
Città #
Genova 23.538
Genoa 4.988
Rapallo 4.270
Vado Ligure 2.617
Bordighera 96
Totale 35.509
Salva come PNG Salva come JPEG
Nome #
Confronto tra gli effeti dei mucolitici N-acetilcisteina, ambroxol, bromexina e sobrerolo sulla sintesi e sulla degradazione di biofilm di Staphylococcus aureus. 1.709
Potentially human pathogenic vibrios in marine and fresh bathing waters related to environmental conditions and disease outcome 249
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 192
DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia. 168
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 164
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 158
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and or invasive Streptococcus pneumoniae strains circulating in Italy 157
Epidemiological study of pathogens isolated from blood in Liguria during 2011. 154
Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms 153
. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 151
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 148
Active surveillance of Streptococcus pneumoniae bacteremia in Italian children 145
A Fatal Case of Nosocomial Legionnaires' Disease: Implications From an Extensive Environmental Investigation and Isolation of the Bacterium From Blood Culture. 145
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 143
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 140
. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance 138
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 138
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 138
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 138
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis 137
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. 136
Antibacterial activity of polyphenols. 135
The role of macrolides in Streptococcus pyogenes pharyngitis. 133
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. 133
Activity of Bay 12-8039 against well-characterised antibiotic resistant S.pyogenes. 130
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 129
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. 129
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 129
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 129
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 128
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 128
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 127
European survey of glycopeptide susceptibility: Staphylococcus spp. 127
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 127
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint 126
Resistance patterns of lower respiratory tract pathogens in Europe. 125
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). 125
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 124
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 124
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 124
Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis). 124
Adesione batterica e fungina a materiali protesici del cavo orale. 123
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 123
In vitro antimicrobial activity of tigecycline against Gram-negative and Gram-positive pathogens collected in Northen Italy (T.E.S.T. program 2010). 123
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 122
Epidemiology of multi-resistance Gram negative pathogen circulating in Liguria and molecular characterization of different carbapenemases. 122
Breast implant infection due to Paenibacillus residui in a cancer patient 122
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. 122
Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 119
The oxazolidinones as a new family of antimicrobial agent. 119
Activity of Teicoplanin, Vancomycin and 8 Other Drugs Against Gram-Positive Pathogens Isolated in Italy 119
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC). 118
Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity 118
Detection of macrolide resistance genes in Streptococcus pneumoniae using a rapid method 117
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations 117
Attività antibatterica di N-acetilcisteina sui principali patogeni responsabili di infezioni delle alte vie respiratorie e sui germi del cavo orale. 117
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. 116
Antibiotic persistence: the role of spontaneous DNA repair response 116
Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system 116
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. 114
Pleiotropic effect of sodium arsenite on Escherichia coli 113
Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders 113
Antibiotic resistance among S.pneumoniae isolated in Italy. 113
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections 112
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 111
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 111
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 110
Antibiotic susceptibility patterns and serotypes of nasopharyngeal Streptococcus pneumoniae circulating in healthy italian children. 110
In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. 108
A new in vitro model system to study antimycotic drugs. 108
Evolution of antibiotic resistance in Gram-positive pathogens 107
Characterization of Fluoroquinolone-Resistant Escherichia coli Causing Septicemic Colibacillosis in Calves in Italy: Emergence of a Multiresistant O78 Clonal Group. 107
Microbial epidemiology patterns of surgical infection pathogens. 107
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 107
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 106
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults 105
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. 105
Clinical microbiology of oral cephalosporins 105
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. 105
Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. 105
Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. 105
Antistaphylococcal activity and metabolite profiling of manuka honey (Leptospermum scoparium L.) after in vitro simulated digestion 105
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 105
Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance? 105
Identificazione di resistenze agli antibiotici ben caratterizzate mediante sistema Uro-Quick. 104
In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens 104
Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project 104
Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital 103
Antibiotic persistence: the role of spontaneous DNA repair. 103
Evoluzione di Streptococcus agalactiae verso la resistenza alla penicillina 103
Evaluation of induced and spontaneous contamination of ocular medications after first opening. 103
Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy. 103
Epidemiological study of pathogens isolated from blood in Liguria (January-April 2010). 103
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak 102
Indagine sulla diffusione di stafilococchi resistenti alla meticillina in Liguria 102
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 102
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 102
Bloodstream infections in critically ill patients with COVID-19 102
Epidemiology of serious nosocomial infections: recent data from the Spin survey. 101
AmpC-type plasmid mediated beta-lactamase in Klebsiella oxytoca e K.pneumoniae. 101
Totale 13.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.792
article - articoli 68.811
book - libri 0
conference - conferenze 35.798
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 183
Totale 209.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.019 0 0 0 0 0 0 0 0 685 1.739 1.083 512
2020/20211.899 91 125 134 220 131 204 92 136 303 177 165 121
2021/20224.798 101 376 209 603 278 264 426 1.144 158 449 139 651
2022/20235.162 535 275 125 478 789 976 47 452 902 81 431 71
2023/20242.372 133 355 74 217 213 461 123 158 120 71 116 331
2024/20254.483 191 581 247 430 785 575 565 790 319 0 0 0
Totale 35.730